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Abstract
Coronavirus disease 2019 (COVID-19) is a continuously devastating public health and the world econ-
omy. One of the major challenges in controlling the COVID-19 outbreak is its asymptomatic infection and
transmission, which are elusive and defenseless in most situations. The pathogenicity and virulence of
asymptomatic COVID-19 remain mysterious. Based on the genotyping of 20656 Severe Acute Respira-
tory Syndrome Coronavirus 2 (SARS-CoV-2) genome isolates, we reveal that asymptomatic infection is
linked to SARS-CoV-2 11083G>T mutation, i.e., leucine (L) to phenylalanine (F) substitution at the residue
37 (L37F) of nonstructure protein 6 (NSP6). By analyzing the distribution of 11083G>T in various coun-
tries, we unveil that 11083G>T may correlate with the hypotoxicity of SARS-CoV-2. Moreover, we show a
global decaying tendency of the 11083G>T mutation ratio indicating that 11083G>T hinders SARS-CoV-2
transmission capacity. Sequence alignment found both NSP6 and residue 37 neighborhoods are relatively
conservative over a few coronaviral species, indicating their importance in regulating host cell autophagy
to undermine innate cellular defense against viral infection. Using machine learning and topological data
analysis, we demonstrate that mutation L37F has made NSP6 energetically less stable. The rigidity and
flexibility index and several network models suggest that mutation L37F may have compromised the NSP6
function, leading to a relatively weak SARS-CoV subtype. This assessment is a good agreement with our
genotyping of SARS-CoV-2 evolution and transmission across various countries and regions over the past
few months.
Key words: COVID-19, SARS-CoV-2, NSP6, autophagy, hypotoxicity, algebraic topology, network theory,
machine learning
*Corresponding author. E-mail: weig@msu.edu
i
ar
X
iv
:2
00
7.
01
34
4v
1 
 [q
-b
io.
PE
]  
2 J
ul 
20
20
1 Introduction
The ongoing global pandemic of coronavirus disease 2019 (COVID-19) caused by Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS-CoV-2) has spread to more than 215 countries and territories with 8385440
positive cases and 450686 fatalities as of June 19, 2020 [40]. Unlike SARS-CoV that mainly infects the lower
respiratory tract, SARS-CoV-2 is observed with a high level of shedding at the upper respiratory tract [41].
A wide variety of COVID-19 symptoms have been reported, including fever or chills, body or muscle aches,
headache, stuffy or congested nose, dry cough, fatigue, sore throat, and loss of taste or smell, 2-14 days after
exposure to the virus [41]. Severe symptoms like high fever, severe cough, and shortness of breath indi-
cate the onset of pneumonia. Less common gastrointestinal symptoms like diarrhea, nausea, and vomiting
have been listed at the Centers for Disease Control and Prevention. Currently, symptom-based testing,
contact tracing, isolation, and quarantine are the main strategies for controlling and combating COVID-
19. However, viable viruses have also been isolated from asymptomatic cases [31]. Asymptomatic and
presymptomatic cases can play an important role in transmitting coronavirus [23]. Elusive asymptomatic
transmission is regarded as the Achilles heel of current strategies to control COVID-19 [24]. Early stud-
ies with 235 cases of influenza virus infections indicate that the duration of influenza viral shedding was
shorter and decayed faster and quantitative viral loads were lower in asymptomatic than in symptomatic
cases. [27] The epidemiological and virological characteristics of COVID-19 asymptomatic pathogenicity
remains a mystery.
SARS-CoV-2 is a non-segmented positive-sense RNA virus that belongs to the β-coronavirus genus,
coronaviridae family, and Nidovirales order. Many RNA viruses, such as the flu virus, are prone to muta-
tions due to the lack of proofreading in their genetic evolutions. Viral mutations are driven by a variety of
factors, including replication mechanism, polymerase fidelity, access to proofreading or post-replicative re-
pair, sequence context, cellular environment, and host immune responses or gene editing [34]. Benefit from
an error-correction mechanism common to the Nidovirales order, the replication of coronavirus is regu-
lated by a bi-functional enzyme nonstructure protein 14 (NSP14) [19]. Therefore, SARS-CoV-2 maintains
relatively high accuracy in virus replication and transcription compared with the flu virus. Nonetheless,
SARS-CoV-2 has had 10620 single mutations for the genome collected on January 5, 2020 [38,42]. Although
the impacts of mutations on SARS-CoV-2 transmission and pathogenicity [2, 20] and COVID-19 diagnosis,
vaccine, and medicine have been studied [38], little is known about the connection between viral evolution
and asymptomatic transmissions.
This work reports the first association of a SARS-CoV-2 single nucleotide polymorphism (SNP) vari-
ant and COVID-19 asymptomatic cases based on the genotyping of 20656 SARS-CoV-2 genome isolates.
We reveal a significant correlation between asymptomatic infections and SARS-CoV-2 single mutation
11083G>T-(L37F) on NSP6. NSP6 is a common protein of α and β-coronaviruses that locate at the en-
doplasmic reticulum (ER) [9]. As a multiple-spanning transmembrane protein, coronavirus NSP6 partici-
pates in viral autophagic regulation. Autophagy degrades alien components to provide an innate defense
against viral infection and promote cell death and morbidity. [32]. In response to extreme cases of starva-
tion, autophagy generates autophagosomes to transfer long-lived proteins, unnecessary or dysfunctional
components to lysosomes for orderly degradation. Studies show that NSP6 undermines the capability of
autophagosomes to transport viral components to lysosomes for degradation by rendering smaller diam-
eter autophagosomes in nutrient-rich media and thus enhancing viral replication [9]. Additionally, NSP6
proteins induce a higher number of autophagosomes per cell compared with starvation to facilitate the
assembly of replicase proteins [4, 9]. Although further studies are required to understand the molecular
mechanism of the NSP6 regulation of autophagy, it is clear that coronavirus NSP6 is extremely important
to viral protein folding, viral assembly, and the replication cycle. It is of paramount importance to under-
stand how NSP6 mutation L37F leads to COVID-19 asymptomatic transmission and reduced virulence.
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We show that NSP6 is a relatively conservative protein and the region around residues is quite conserva-
tive over several SARS-CoV-2 related genomes to maintain the crucial regulative function of NSP6. Using
artificial intelligence (AI), topological data analysis (TDA), and a variety of network models, we further
demonstrate that mutation L37F disrupts the folding stability of NSP6. We uncover the correlation between
NSP6 mutation L37F and weakened SARS-CoV-2 virulence. We also analyze the global transmission and
find the decay tendency of NSP6 mutation L37F. We prove that the evolutionary dynamics of L37F is age-
and gender-independent.
2 Results
We analyze 20656 SARS-CoV-2 complete genome sequences deposited in GISAID ( https://www.gisaid.o
rg/) database up to June 19, 2020. Among them, 7243 samples have patient status information recorded as
asymptomatic, symptomatic, hospitalized, ICU, deceased, and so on. In particular, 83 samples are labeled
with asymptomatic (53) and symptomatic (30) cases. By genotyping 53 genome samples, we find that
mutation 1083G>T is significantly relevant with asymptomatic infection with a p-value being much smaller
than 0.05. Mutation 11083G>T changes leucine (L) residue at position 37 of NSP6 to phenylalanine (F),
denoted as L37F.
In the following sections, we investigate the relationship between mutation 11083G>T-(L37F) and asymp-
tomatic infections using both gene-specific analysis and protein-specific analysis. The global evolution and
transmission pathway of the mutation is studied as well.
2.1 Gene-specific analysis
Our customized dataset generated from genotyping 20656 SARS-CoV-2 complete genome sequences down-
loaded from the GISAID database is summarized in Table 1. Here, patient status referred to as incomplete
records of asymptomatic, symptomatic, hospitalized, deceased, gender, etc. Additionally, our dataset con-
tains data collection dates and locations of genome isolates. The detailed information of our dataset is
available in the Supporting information.
Table 1: Characteristics of customized dataset
Sample size With 11803G>T With patient status Asymptomatic Symptomatic
20656 2305 7243 53 30
We first analyze 83 sequences that have either asymptomatic or symptomatic labels submitted from
Japan. The statistic analysis shows that the Pearson correlation coefficient between asymptomatic records
and 10083G>T is 0.606. Moreover, the p-value is 1.29×10−9, which reveals the significant relevance be-
tween asymptomatic and single mutation 11083G>T-(L37F). Next, we split our genotyping dataset of 20656
sequences into different countries and extract those records with the 11083G>T mutation. Table 2 summa-
rizes the total number of sequences related to 11083G>T-(L37F), denoted as NL37F, the total number of
sequences NS, the 11083G>T-(L37F) ratio, the number of total cases, the number of total deaths, and the
death ratio of 25 countries up to June 19, 2020, respectively. A complete table for all countries/regions can
be found in the Supporting information.
Table 2 suggests that the 11083G>T-(L37F) ratio correlates with the death ratio. For example, Singapore
has the highest 11083G>T-(L37F) mutation ratio as of 0.644. A piece of recent news reported that half of the
COVID-19 cases in Singapore are symptomless [25], which matches our finding that mutation 11083G>T-
(L37F) is relevant to the asymptomatic infections. Moreover, Singapore has the second-lowest death ratio
as listed in Table 2, suggesting that single mutation 11083G>T-(L37F) may have weakened SARS-CoV-2
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Table 2: The 11083G>T-(L37F) mutation ratio and death ratio in each country as of June 19,2020. Here, NL37F and NS represent
the total number of sequences with 11083G>T-(L37F) and the total number of sequences in each country listed in our dataset,
respectively.
Country/Region NL37F NS Mutation ratio Total cases Total deaths Death ratio
Singapore 203 315 0.644 41473 26 0.06%
Japan 60 103 0.583 17740 935 5.27%
Turkey 24 66 0.364 184031 4882 2.66%
Jordan 7 22 0.318 1001 9 0.90%
India 166 540 0.307 380532 12573 3.30%
Norway 7 28 0.250 8629 244 2.83%
Australia 235 1141 0.206 7391 102 2.28%
South Korea 5 25 0.200 12306 280 2.28%
Iceland 77 425 0.181 1816 10 0.55%
United Kingdom 902 6037 0.149 300473 42288 14.07%
Thailand 7 58 0.121 3146 58 1.84%
Indonesia 1 9 0.111 42762 2339 5.47%
Canada 18 280 0.064 99853 8254 8.27%
Vietnam 3 47 0.064 342 0 0.00%
Belgium 33 599 0.055 60384 9683 16.04%
Italy 6 109 0.055 238159 34514 14.49%
South Africa 3 55 0.055 83890 1737 2.07%
China 15 284 0.053 84940 4645 5.47%
France 11 230 0.048 153557 29537 19.24%
United States 236 5835 0.04 2149166 117472 5.47%
Brazil 5 124 0.04 955377 46510 4.87%
Switzerland 7 180 0.039 31117 1677 5.39%
Spain 12 384 0.031 245268 27136 11.06%
Chile 5 161 0.031 225103 3814 1.69%
Russia 2 166 0.012 569063 7814 1.37%
virulence. A similar deduction can be obtained from the records of Turkey, Jordan, Norway, Australia,
and South Korea. The relatively high 11083G>T-(L37F) mutation ratio (greater than 0.200) with a corre-
spondingly low death ratio (less than 3.00%) further validates that 11083G>T-(L37F) may be relevant to
the asymptomatic-induced the hypotoxicity of SARS-CoV-2. Moreover, 11 out of 17 countries whose mu-
tation ratios are less than 0.200 have a death ratio greater than 4.5%. The death ratios of the United King-
dom, Belgium, France, and Spain are even higher than 10%, which supports our assumption that mutation
11083G>T-(L37F) weakens SARS-CoV-2 virulence.
Figure 1 illustrates the number of complete SARS-CoV-2 sequences in our dataset with 11083G>T-(L37F)
detected versus the number of complete SARS-CoV-2 sequences without 11083G>T-(L37F) detected every
10 days in Singapore, Japan, India, China, United Kingdom, Italy, United States, Australia, and Spain, as
well as two states in the United States: New York and Washington. The blue and red bar represents the
11083G>T-(L37F) counts and other mutation counts every ten-day period, respectively. Similar bar plots
for all countries/regions involving this specific mutation can be found in the Supporting information. Sin-
gapore’s plot shows that 11083G>T was widely found after March 24, 2020, which is consistent with the
report saying that at least half of Singapore’s newly discovered COVID-19 cases show no symptoms [25].
Almost all of the cases collected from February 12 to February 22 have 11083G>T mutation with asymp-
tomatic infections recorded, which is the most robust evidence to associate the SARS-CoV-2 11083G>T
or L37F mutation on NSP6 with the asymptomatic infections. India is one of the countries that also have a
large number of 11083G>T mutation cases. Recent news reported that 80 percent of all coronavirus patients
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in India were asymptomatic or showed mild symptoms [12], which supports our deduction that 11083G>T
correlates with the asymptomatic infection. Moreover, one can see that mutation 11083G>T in China, the
United Kingdom, and Australia is not as abundant as in Singapore, Japan, or India. Furthermore, as dis-
cussed before, the asymptomatic infection may associate with the hypotoxicity of SARS-CoV-2 as well.
Note that from Figure 1, China, the United States, Spain, and Italy have a relatively lower occurrence of
11083G>T, which may contribute to the relatively high death ratio.
Figure 1: The time evolution of SARS-CoV-2 mutation 11083G>T-(L37F) in nine countries and two states (i.e., New York and Wash-
ington) from the United States. The bar plots show the frequency of cases with and without 11083G>T-(L37F) mutation. Each bar
width covers a 10-day period. The blue line plot illustrates the evolution of the L37F mutation ratio computed as the count of genome
sequences having the L37F mutation over the total count of genome sequences at each time period. The red line plot shows the
evolution of the total count of genome sequences.
However, this specific mutation is not the only factor in determining the death ratio. The number of total
infected cases, diagnostic testing, medical and health conditions, age structure, nursing-home population,
etc. are also critical factors. For example, Japan has a second-highest ratio of 11083G>T-(L37F), while
the death ratio is greater than 5 percent. Similarly, the United Kingdom has the third-highest death ratio,
suggesting its ratio of mutation 11083G>T-(L37F) is not at the last echelon. One of the possible reasons is
that the healthcare system was heavily broken by a sudden increase in infected cases. The lack of proper
healthcare attention to a large number of mid/severe COVID-19 cases resulted in a high mortality ratio.
Note that although Russia has the lowest 11083G>T-(L37F) mutation ratio lists in Table 2, its 1.37% death
ratio caused by COVID-19 is also relatively low. One possible reason is Russia’s relatively low median age.
In total, 53 genome samples were related to 11083G>T among 542 samples that were collected from May
14 to May 24 in New York. After that, fewer cases were collected in New York and the 11083G>T mutation
ratio decreased. Also, the state of Washington had a small proportion of 11083G>T mutation before May
13, 2020. In the first week of June, 26 out of 27 genome sequences had mutation 11083G>T, which may
indicate that the asymptomatic infection is becoming increasingly prevalent in Washington.
During the last few months, the proportion of the 11083G>T mutation in the United Kingdom has
gone down as shown in Figure 1. Globally, the ratio of samples with the 11083G>T mutation over all
samples, shown in the middle chart of the last row in Figure 1 decays over time, suggesting the mutation
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is unfavorable to the viral transmission. Two abnormal peaks appeared on February 22 and June 2 in the
ratio were due to the L37F mutation counts from Japan and Washington, respectively. The relatively small
numbers of total genome sequences at these dates induce the jumps. Unfortunately, the number of genome
sequences decays rapidly after April as shown in Figure 1, while globally, the number of SARS-CoV-2
infections increasing steadily according to the WHO’s daily situation reports ( https://www.who.int/em
ergencies/diseases/novel-coronavirus-2019/situation-reports).
2.2 Evolution and transmission analysis
In this section, we track the global transmission pathways of the single mutation 11083G>T-(L37F) to un-
derstand its spread dynamics. We found that the first genome containing single mutation 11083G>T-(L37F)
was sequenced in Chongqing, China, on January 18, 2020, which can be considered as the ancestor of
11083G>T in our dataset. However, the complete genome sequences released on the GISAID do not include
all of the infected cases. Mutation 11083G>T also detected in a co-mutation record [8782C>T, 11083G>T,
28144T>C] in Yunnan, China one day earlier than Chongqing’s sequence, which indicates that the true
ancestor of 11083G>T might have occurred early than January 18, 2020. Note that the first SARS-CoV-2
sequence released in GISAID was collected in Wuhan, China on December 24, 2019. China’s COVID19 epi-
center, Wuhan, implemented a lockdown on January 23, 2020, which explains why China has a relatively
low ratio of 11083G>T-(L37F) mutation.
The first confirmed case reported by the Singapore government was on January 23, 2020. Interest-
ingly, the first genome sequence related to mutation 11083G>T-(L37F) was found in Singapore on January
29,2020, only a few days after the first confirmed cases. Therefore, the transmission of COVID-19 in Sin-
gapore at the initial stage contains a large proportion of the11083G>T-(L37F) mutation. The prevalence of
the11083G>T-(L37F) mutation in Singapore’s SARS-CoV-2 infections explains its low death ratio.
Mutation 11083G>T-(L37F) first appeared in the United States on January 22, 2020, in Arizona, a 26-
year-old male with co-mutations [8782C>T, 11083G>T, 28144T>C, 29095C>T], which is the descendant
of [8782C>T, 11083G>T, 28144T>C] found in China. Since then, more records related to 11083G>T have
appeared in the United States. At this stage, 236 genome isolates from the United States in our dataset are
relevant to 11083G>T. France and Italy are the following countries that found the 11083G>T mutation at an
early stage. Both of them detected this mutation on Jan 29, 2020. Although 11083G>T mutation has arrived
in the United States and the United Kingdom at a very early stage, different subtypes of SARS-CoV-2 spread
vastly due to their large population, which makes the 11083G>T mutation non-dominated.
In Jordan, the earliest sequence released on GISAID is on March 16, 2020, with 11083G>T mutation,
which indicates the high 11083G>T ratio in Jordan. Note that multiple reasons may lead to a low death
ratio of 0.90% in Jordan. One may be due to the hypotoxicity of SARS-CoV-2 caused by mutation 11083G>T.
The other is that the healthcare system is in good condition due to the small number of infected patients.
The first confirmed COVID-19 cases reported by the Vietnamese government was on January 16, 2020.
However, the first genome isolates related to mutation 11083G>T in our dataset was collected on March
17, 2020. The 11083G>T was found in Vietnam two months after the first confirmed cases, which result
in a low 11083G>T mutation ratio. Surprisingly, none of the patients died in Vietnam. As a low-middle
income country with nearly 100 million population and a much less-advanced healthcare system than other
countries such as Italy, the United Kingdom, and France, Vietnam’s success in tackling COVID-19 attracts
attention. They immediately took action to ban the foreign nationals’ entries and implement strict social
distancing rules, which is the essential factor in keeping the coronavirus death toll at zero.
Figure 2 (a) generated by Highcharts illustrates the distribution and proportion of 11083G>T-(L37F) mu-
tation in the United States. The red and blue represent the 11083G>T-(L37F) mutation and non-11083G>T
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mutations. The color of the dominated type of mutation decides the base color of each state. One can see
that Oregon, Alaska, Texas, and Ohio have a higher proportion of 11083G>T than the other states, while the
death ratio in Oregon, Alaska, and Texas is lower than the average death ratio (5.47%) in the United States
as of June 19, 2020. Note that although the ratio of mutation 11083G>T in Nevada is 1, only one genome
sequence was submitted from Nevada; hence, it is insignificant in the statistics.
Figure 2 (b) created by using Highcharts illustrates the distribution and proportion of the 11083G>T-
(L37F) mutation in the world. Mutation 11083G>T-(L37F) only dominated in a few countries such as Japan,
Singapore, Pakistan, Jamaica, Kenya, Belarus, and Brunei. Most of the other countries have a small pro-
portion of mutation 11083G>T-(L37F). Detailed information for all countries/regions is available in the
Supporting information.
Figure 2: (a) Pie chart plot of the distribution of genome samples with and without the 11083G>T-(L37F) mutation in the United
States. The red and blue colors represent the 11083G>T-(L37F) mutation and non-11083G>T mutations, respectively. The color of
the dominated mutation type decides the base color of each state. (b) Bar plot of the age and gender distributions of the ratio of the
number of samples having mutation L37F over the total number of samples having age and/or gender labels. The straight lines over
all age groups are the group average ratios (the average ratio from the total dataset having age labels overlaps with the average ratio
from the dataset having male labels.). (c) Pie chart plot of the distribution of genome samples with and without the 11083G>T-(L37F)
mutation in the world. The color of the dominated mutation decides the base color of each country.
Figure 2 (c) displays the potential age and gender disparities in mutation 11083G>T-(L37F). Among
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20656 complete genome sequences, 9923 cases have age labels and 9437 cases (male cases: 4993 and female
cases: 4444) have gender labels, which are used for our age-related and gender-related analysis, respec-
tively. Overall, male cases have a slightly higher ratio of the 11083G>T-(L37F) mutation than female cases.
In terms of age distribution, the ratio is significantly higher in the age group of 99-109 years. However, only
7 cases fall into this group and all data were collected from the United Kingdom (2 cases) and Singapore (5
cases). More data and further studies are required to draw any conclusion from this group. Therefore, we
conclude that mutation 11083G>T-(L37F) is quite evenly distributed over age and gender groups, implying
that the mutation does not have a host-dependent behavior.
2.3 Protein-specific analysis
Figure 3 depicts the sequence and structural information of NSP6. Figure 3 (a) is generated by an online
server [30], Figure 3 (b) is plotted by PyMol [11], and Figure 3 (c) is created by [1]. As shown in Figure 3(a),
NSP6 is a multi-span membrane protein. In mutation 11083G>T-(L37F), both leucine and phenylalanine
are α-amino acids and non-polar. However, phenylalanine has a benzyl ring on the side chain, making
the secondary structure of NSP6 more compact. As shown in Figures 3(a) and (c), from the NSP6 protein
residue position 34 to 37, the residues are FFFL. Therefore, there will be four continuous phenylalanine
amino acid FFFF after the L37F mutation. As a result, mutation L37F can stiffen the NSP6 structure by the
aromatic-aromatic, hydrophobic, or pi-stacking interactions. Such an additional interaction can significantly
change NSP6 function [4].
Figure 3(c) presents the alignment of the SARS-CoV-2 NSP6 sequence with those of the other four coro-
naviruses, including that of SARS-CoV. The sequence identities between SARS-CoV-2 NSP6 and the NSP6s
of SARS-CoV [28], RaTG13 [46], ZC45 [26], BM48-31 [13] are 87.2%, 99.7%, 97.9%, and 83.8%, respectively.
Note that the overall sequence identity between SARS-CoV-2 and SARS-CoV is 83.8%. Therefore, NSP6 is
relatively conservative. Additionally, NSP6 position 37 is in a relatively conservative environment among
different species. Position 37 for all other species is valine, which is also hydrophobic and extremely similar
to leucine. Two amino acids differ by one -CH2- unit. A large region from 25 to 45 has only three mutations
among five species, indicating the region is potentially important for the protein function.
There three-dimensional (3D) structure of NSP6 is displayed in Figure 3(b). To further understand
the impact of mutation L37F on NSP6, we carry several theoretical analyses using AI [6], TDA [8], flex-
ibility and rigidity index (FRI) [43], and a large number of other network theory models [15]. Our re-
sults are summarized in Table 3. The protein folding stability change following mutations is defined by
∆∆G = ∆Gm − ∆Gw, where ∆Gw is the free energy change of the wild type and ∆Gm is the free energy
change of the mutant type [6]. The folding stability change ∆G measures the difference between folded
and unfolded states. Thus, a negative ∆∆G means the mutation causing destabilization and vice versa. We
use a TDA-based deep learning method [6] to compute ∆∆G in this work. As shown in Table 3, a negative
folding stability change ∆∆G is found for the mutation, indicating a destabilizing mutation L37F for NSP6.
Physically, a large hydrophobic residue (F) at the lipid bilayer and solvent interface reduces NSP6 stability.
Considering the sequence alignment in Figure 3(c), we have also carried a similar calculation for the muta-
tion of L37V and found its ∆∆G = −0.71 kcal/mol. Therefore, leucine is favored at residue position 37 for
SARS-CoV-2 NSP6.
Next, the FRI rigidity index Rη measures the geometric compactness and topological connectivity of
the network consisting of Cα at each residue and the heavy atoms involved in the mutation [43]. The
scale parameter η determines the range of pairwise interactions. In this work, the parameter η is set to
8A˚. As shown in Table 3, the increase in the FRI rigidity index Rη is found, indicating the increase in
the rigidity of the first alpha helix of NSP6. It is known that protein flexibility is required to allow it to
function through molecular interactions within the cell, among cells and even between organisms [37]. The
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Figure 3: (a) The visualization of SARS-CoV-2 NSP6 proteoform. The 11083G>T mutation in the genome sequence leads to the
residue 37 leucine (L) mutant to phenylalanine (F). We use a red arrow to point out the mutation detected at residue 37. According
to the sequence alignment results in (c), we color the conservative SARS-CoV-2 NSP6 residues by blue. (b) The 3D structure of SARS-
CoV-2 NSP6 protein. Green represents the mutation residue at position 37 of NSP6. (c) Sequence alignments for the NSP6 proteins
of SARS-CoV-2, SARS-CoV, bat coronavirus RaTG13, bat coronavirus CoVZC45, bat coronavirus BM48-31. The numbering is labeled
according to SARS-CoV-2.
quadruplet phenylalanine resulting from mutation L37F can significantly reduce NSP6’s interactions with
ER.
Moreover, seven network models [15] are utilized to analyze the L37F mutation in NSP6 as shown in
Table 3. We consider the network of heavy atoms at residue 37 and Cα atoms in NSP6. The connections
are allowed between any pair of atoms within a cutoff distance of 8.0 A˚. The mutation-induced decrease in
the edge density d is due to the factor that the mutation increases the edge on the surface of the protein.
The mutation induced the decrease in the average path length 〈L〉 is owing to the mutation increases the
edge with shorter distances. The mutation induced the decrease in average betweenness centrality 〈Cb〉 is
due to the increase in the crowd of vertices by the mutation residue. The mutation induced the increase in
average eigencentrality 〈Ce〉 is because increase in the number of the connected components will enlarge
the maximal eigenvalues. The mutation induced the increase in the average subgraph centrality 〈Cs〉 is
due to the decrease in the average participating rate of each edge. The mutation induced the decrease in
average communicability 〈M〉 is due to the decrease in the neighbor edges participating rate of each edge.
Finally, the mutation induced the increase in average communicability angle 〈Θ〉 is due to the increase in
the alignments among different edges. Together with the FRI rigidity index and the protein folding stability
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Table 3: The folding stability change and graph network descriptor consisting of wild type and mutant type of NSP6 calculated by
web server [6]. The folding stability change ∆∆G = ∆Gm − ∆Gw , where ∆Gm is free energy change of wild type and ∆Gw is
free energy change of mutation type. R8: FRI rigidity index with η of 8; d: edge density; 〈L〉: average path length; 〈Cb〉: average
betweenness centrality; 〈Ce〉: average eigencentrality; 〈Cs〉: average subgraph centrality; 〈M〉: average communicability; 〈Θ〉:
average communicability angle.
Mutation L37F Destabilizing
∆∆G -0.74 kcal/mol
Descriptors Wild type Mutant type Relative change (%)
R8 19.73 19.83 0.50
d 0.05816 0.05779 -0.64
〈L〉 22.7394 22.7373 -0.01
〈Cb〉 0.00943 0.00942 -0.11
〈Ce〉 0.03508 0.03514 0.17
〈Cs〉 8786858 8820927 0.39
〈M〉 2826948 2822450 -0.16
〈Θ〉 1.8399 1.8731 1.77
changes, these network assessments show that NSP6 becomes unstable and less functional after the L37F
mutation [4].
Conclusion
While the asymptomatic infections of severe acute respiratory syndrome 2 (SARS-CoV-2) have been re-
ported worldwide in the past few months, little is known about the formation mechanism and virological
characteristics of asymptomatic infections. This work parses 20656 complete genome sequences of SARS-
CoV-2, and for the first time, reveals the relationship between asymptomatic cases and a single nucleotide
mutation 11083G>T-(L37F) on NSP6. After genotyping 83 sequences with asymptomatic and symptomatic
records, we find 11083G>T is significantly relevant to the asymptomatic infection. By analyzing the dis-
tribution of 11083G>T in various countries, we unveil that the 11083G>T mutation correlates with the
death ratio in Singapore, the United States, the United Kingdom, etc, inferring the correlation between
the asymptomatic infection and the hypotoxicity of SARS-CoV-2. Moreover, we track the dynamics of
11083G>T mutation ratio globally and discover its decaying tendency, indicating that 11083G>T mutation
hinders SARS-CoV-2 transmission. Furthermore, the analysis of the distribution of 11083G>T in differ-
ent ages and genders unveils that 11083G>T-driven mutation does not have a host-dependent behavior.
The protein-specific analysis is also taken into consideration. The 11083G>T mutation leads leucine (L)
residue at position 37 of NSP6, changing to phenylalanine (F). By employing the graph network analysis
and topology-based mutation predictor, we find that 11083G>T-(L37F) destabilizes the structure of NSP6
in protein-wise. As one of the most conservative proteins of SARS-CoV-2, NSP6 involves in the viral au-
tophagic regulation. Therefore, this destabilized mutation may result in the inefficiency of NSP6 to partici-
pate in the viral protein folding, viral assembly, and replication cycle, which underpins our deduction that
11083G>T-(L37F) may be relevant to the asymptomatic infections and weaken the SARS-CoV-2 virulence.
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Supporting Information
Additional Analysis
Visualization of four coronaviral NSP6s in membrane
Figure 4 is the visualization of four NSP6 proteoforms of SARS-CoV, Bat-SL-RaTG, Bat-SL-CoVZC45, and
Bat-SL-BM48-31. These proteoforms are consistent with that of SARS-CoV-2 described in the main paper,
indicating their similar function of regulating cell autophagy.
Figure 4: The visualization of NSP6 proteoforms for a few species close to SARS-CoV-2. (a) SARS-CoV, (b) Bat-SL-RaTG13, (c) Bat-SL-
CoVZC45, and (d) Bat-SL-BM48-31.
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Network analysis of the SARS-CoV-2 NSP3 L37F mutation
(a) (b)
(c) (d)
(e) (f)
Figure 5: Network analysis of the SARS-CoV-2 NSP6 L37F mutation. The networks consist of heavy atoms of mutation site 37 and
Cα atoms of SARS-CoV-2 NSP6. The differences of descriptors between the network with wild type, leucine, and the network with
mutant type, phenylalanie, are displayed. (a) FRI rigidity index differences; (b) eigencentrality differences; (c) subgraph centrality
differences; and (d) betweenness centrality differences. In (e) and (f), relative changes versus cutoff distances to the mutation site
are studied. (e) relative changes of FRI rigidity index, path length, edge density, betweenness centrality, and eigencentrality; and (f)
relative changes of subgraph centrality, communicability, and communicability angle.
Figure 5 shows the network analysis of the SARS-CoV-2 L37F mutation. The networks are constructed
by heavy atoms at the mutation site and at the Cα atoms of SARS-CoV-2 NSP6. Figures 5 (a), (b), (c), and
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(d) present the mutation-induced differences of FRI rigidity index differences, eigencentrality differences,
subgraph centrality differences, and betweenness, respectively. Although these descriptors do not change
much globally, their local changes around the mutation site reveal the L37F mutation-induced stress around
the mutation site.
Figures 5 (e) and (f) show the dependence of relative changes over cutoff distances. First of all, every
descriptor converges as the cutoff distance increase. Relative changes do not fluctuate for cutoff distance
greater than 24 A˚. The relative change of FRI rigidity index monotonically decreases in absolute value as the
cutoff increases. Similarly, the edge density has a monotonically decreasing pattern. The two networks are
close in the path length descriptor. Interestingly, betweenness centrality descriptor has the largest difference
at 10 A˚ cutoff distance, while the eigencentrality descriptor has the largest difference at 22 A˚ cutoff distance.
For betweenness centrality, it shows that the mutation has the largest impact in the network of Cα within
10 A˚ to any atoms of the target residue. In Figure 5 (f), three descriptors show a similar pattern — they
increase in absolute value first and then decrease eventually as the cutoff increases. Overall, the relative
change plots indicate that the mutation happening at L37 has the largest impact on the Cα within 10 A˚ to
any atoms of the target residue.
Material and Methods
Data collection and pre-processing
On January 5, 2020, the complete genome sequence of SARS-CoV-2 was first released on GenBank (Access
number: NC 045512.2) by Zhang’s group at Fudan University [42]. Since then, there has been a rapid
accumulation of SARS-CoV-2 genome sequences. In this work, 20,656 complete genome sequences with
high coverage of SARS-CoV-2 strains from the infected individuals in the world were downloaded from the
GISAID database [35] ( https://www.gisaid.org/) as of June 19, 2020. All the records in GISAID without
the exact submission date were not taken into considerations. To rearrange the 20,656 complete genome
sequences according to the reference SARS-CoV-2 genome, multiple sequence alignment (MSA) is carried
out by using Clustal Omega [36] with default parameters.
The amino acid sequence of NSP6 is downloaded from GenBank [3]. The three-dimensional (3D) struc-
ture of nonstructure protein 6 (NSP6) in this work is generated by I-TASSER model [44]. The 3D structure
graph is created by using PyMOL [11].
Single nucleotide polymorphism genotying
Single nucleotide polymorphism (SNP) genotyping measures the genetic variations between different mem-
bers of a species. Establishing the SNP genotyping method to the investigation of the genotype changes
during the transmission and evolution of SARS-CoV-2 is of great importance [38, 45]. By analyzing the re-
arranged genome sequences, SNP profiles, which record all of the SNP positions in teams of the nucleotide
changes and their corresponding positions, can be constructed. The SNP profiles of a given SARS-CoV-2
genome isolated from a COVID-19 patient capture all the differences from a complete reference genome
sequence and can be considered as the genotype of the individual SARS-CoV-2.
Topology-based prediction of protein folding stability changes upon mutation
In this work, the prediction of NSP6 folding energy changes upon mutation is computed by using the
topology based mutation predictor (TML-MP) ( https://weilab.math.msu.edu/TML/TML-MP/) which is
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briefly reviewed as following and its detail can be found in the literature [6]. TML-MP applies element
specific persistent homology, which reveals essential biological information [8,14]. The method employs the
element-specific persistent homology [7] and other biological and chemical properties as machine learning
features to train gradient boosted regression tree (GBRT) models. The dataset includes 2648 mutations
instances in 131 proteins provided by Dehouck et al [10]. The error analysis based on the dataset is given
as Pearson correlations coefficient (Rp) of 0.79 and root mean square error (RMSE) of 0.91 kcal/mol from
previous work [6].
As the persistent homology widely applied in a variety of practical feature generation problems, it is
also successful in the implementation of predictions of protein folding energy changes upon mutation. The
key idea in TML-MP is to use the element-specific persistent homology (ESPH) which distinguishes differ-
ent element types of biomolecules when building persistent homology barcodes. For instance, commonly
occurring protein element types include C, N, O, S, and H. However, hydrogen atoms are often absent from
PDB data and sulfur atoms are too few in most proteins to be statistically important. Thus, C, N, and O
elements are considered on the ESPH in protein characterization. As for persistent homology, barcodes
generated based on ESPH provide a topological representation of molecular interactions. Features are ex-
tracted from the different dimensions of persistent homology barcodes by dividing barcodes into several
equally spaced bins, which is called binned barcode representation. The auxiliary features such as geom-
etry, electrostatics, amino acid types composition, and amino acid sequence are also included for machine
learning training.
The element specific persistent homology is built by adopting the distance function DI(Ai, Aj) describ-
ing the distance between two atoms Ai and Aj defined as
DI(Ai, Aj) =
{
∞, if Loc(Ai) = Loc(Aj),
DE(Ai, Aj), otherwise,
(1)
where Loc(·) denotes the location of an atom which is either in a mutant site or in the rest of the protein
andDE(·, ·) is the Euclidean distance between the two atoms. Then, the persistent homology uses simplicial
complexes with a specific rule such as Vietoris-Rips complex, Cech complex, or alpha complex. Vietoris-
Rips complex (VC) is used for characterizing first-order interaction where alpha complex (AC) is used
for characterizing higher-order patterns. Using ESPH to characterize interactions of different kinds, we
construct persistent homology barcodes on the atom sets by selecting one certain type of atoms in mutation
site and one other certain type of atoms in the rest of the protein. The set of barcodes from one persistent
homology computation as V p,d,bγ,α,β where
• p ∈ {VC,AC} is the complex rule,
• d ∈ {DI,DE} is the distance function,
• b ∈ {0, 1, 2} is the topological dimensions,
• γ ∈ {M,W} is the protein of mutant type or wild type,
• α ∈ {C,N,O} is the element type selected in proteins except in the mutation site,
• β ∈ {C,N,O} is the element type selected in the mutation residue.
These barcodes are capable of reflecting the molecular mechanism of protein stability. Features are ex-
tracted from the groups of persistent homology barcodes. For 18 groups of Betti-0 ESPH barcode such that
9 groups are from the mutant type and 9 groups are from the wild type, one can specify a fixed length
interval to divide the ESPH barcodes into a number of equally spaced bins. For example, a length set,
{[0, 0.5], (0.5, 1], ..., (5.5, 6]A˚} would turn the 18 groups of Betti-0 ESPH barcode into 18*12 features with
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dimension of the number of atoms. The death and birth of bars are counted in each bin resulting in fea-
tures. Therefore, this representation enables us to precisely characterize hydrogen bonds, van der Waals,
electrostatic, hydrophilic, and hydrophobic interactions. For the higher-order Betti numbers, the emphasis
is given on patterns of both short and long-distance scales. Statistics feature are computed for each group
of barcodes for Betti-1 and Betti-2, which are sum, max, and the average of bar length, and max and min
of birth and death values. Overall, 12*18 features are generated by Betti-0 on VC, and 7*2*18 features are
generated by Betti-1 and Betti-2 on AC.
In TML-MP, gradient boosted regression trees (GBRTs) [22] are employed to train the dataset according
to the size of the training dataset, absence of model overfitting, non-normalization of features, and ability
of nonlinear properties. The GBRT method produces a prediction model as an ensemble method which is a
class of machine learning algorithms. It builds a popular module for regression and classification problems
from weak learners. By the assumption that the individual learners are likely to make different mistakes,
the method uses a summation of the weak learners to eliminate the overall error. Furthermore, a decision
tree is added to the ensemble depending on the current prediction error on the training dataset. Therefore,
this method is relatively robust against hyperparameter tuning and overfitting, especially for data with a
moderate number of features. The GBRT is shown for its robustness against overfitting, good performance
for moderately small data sizes, and model interpretability. The current work uses the package provided
by scikit-learn (v 0.23.0) [33].
Graph network models
The graph network descriptors are briefly presented which are applied in this work. Graph networks can
mimic interactions between pairs of units in molecules. The quantify features of the networks can reveal
the biological and chemical properties measured by comparing descriptors on different networks. To detect
the single residue impact following mutation, the network consists of a set S(r) of Cα atoms from every
residue of protein structure except the target mutation residue where r is the cutoff distance such that a Cα
atom is included if it is within r A˚ to any atom of the target mutation. The total atom set T (r) is defined as
the atoms (C, N, and O) of the target residue and Cα atoms of S(r). Moreover, two vertices are connected
in the network if their distance is less than 8 A˚. Thus the adjacency matrix A can be defined as well where
A is a matrix containing 0 and 1 such that A(i, j) = 0 if i-th and j-th are disconnected and A(i, j) = 1 if i-th
and j-th are connected.
FRI rigidity index
FRI rigidity index was introduced to reflect the flexibility between atoms for molecular interaction predic-
tion [29, 43]. The single residue molecular rigidity index measures its influence on the set S(r) which is
given as
Rη =
NS∑
i=1
N∑
j=1
e
( ‖ri−rj‖
η
)2
, (2)
where NS is the number of Cα atoms of the set S(r) and N is the number of atoms in total atom set T (r).
Edge density
Edge density is defined based on the adjacency matrix of the total atom set T (r) such as
d =
1
NS
N∑
i=1,i/∈IT
N∑
j=1
A(i, j), (3)
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where IT is the index set of the mutation residue.
Average path length
Average path length measures the separation between two vertices of the whole network, which can be
used to study infectious diseases spreading in the networks [39]. The average path length for the single
mutation system of biomolecular is defined as
〈L〉 = 1
2NS(N − 1)
N∑
i=1,i/∈IT
N∑
j=1
d(i, j), (4)
where d(i, j) is the shortest path length between vertices vi and vj .
Average betweenness centrality
Average betweenness centrality shows communications in a network [21]. The average betweenness cen-
trality is given as
〈Cb〉 = 1
NS
N∑
k=1,k/∈IT
N∑
i=1
N∑
j=i+1
gkij
gij
, (5)
where gkij is defined as the number of the shortest path between vertices vi and vj that passes vk, and gij is
the number of shortest paths between vi and vj .
Average egeincentrality
Average egeincentrality is the average of elements of the eigenvector Vmax, which is corresponding to the
largest eigenvalues of the adjacency matrix [5] such as
〈Ce〉 = 1
NS
N∑
i=1,i/∈IT
ei. (6)
Average subgraph centrality
Average subgraph centrality is built on the exponential of the adjacency matrix, E = eA. The subgraph
centrality is the summation of weighted closed walks of all lengths starting and ending at the same node [15,
18]. Thus the average subgraph centrality reveal the average of participating rate of each vertex in all
subgraph, which is given as
〈Cs〉 = 1
NS
N∑
i=1,i/∈IT
E(i, i). (7)
Average communicability
Average communicability is defined in a similar way as the subgraph centrality on the exponential of the
adjacency matrix [15–17], which is
〈M〉 = 1
NS(N − 1)
N∑
i=1,i/∈IT
N∑
j=1
E(i, j), (8)
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Average communicability angle
Average communicability angle is given by [17]
〈Θ〉 = 1
NS(N − 1)
N∑
i=1,i/∈IT
N∑
j=1
θ(i, j), (9)
where θ(i, j) = cos−1
(
E(i,j)√
E(i,i),E(j,j)
)
.
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